AβPP intracellular C-terminal domain function is related to its degradation processes

Journal of Alzheimer's Disease

Volumn 30, Issue 2, 2012, Pages 393-405

  Buoso, Erica ^a   Biundo, Fabrizio ^a   Lanni, Cristina ^a   Schettini, Gennaro ^b   Govoni, Stefano ^a   Racchi, Marco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AICD; A PP; Fe65; IDE; proteasome; Tip60

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN INTRACELLULAR C TERMINAL DOMAIN; INSULINASE; METALLOPROTEINASE INHIBITOR; PROTEASOME; PROTEIN FE65; TIP60 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE CONTROL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 84861515874     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111961     Document Type: Article

References (55)

1. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
2. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, Lieberburg I, Schenk DB (1993) Secretionofbeta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260-263. (Pubitemid 23034476)
3. Ryan KA, Pimplikar SW (2005) Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 171, 327-335. (Pubitemid 41540024)
4. Kimberly WT, Zheng JB, Guénette SY, Selkoe DJ (2001) The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notchlike manner. J Biol Chem 276, 40288-40292.
5. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: Cell fate control and signal integrationindevelopment. Science 284, 770-776. (Pubitemid 29291335)
6. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522.
7. Schroeter EH, Kisslinger JA, Kopan R (1998) Notch-1 signalling requires ligand-induced proteolytic release of intra-cellular domain. Nature 393, 382-386. (Pubitemid 28269713)
8. McLoughlin DM, Miller CC (1996) The intracellular cyto-plasmic domainof the Alzheimer's disease amyloid precursor protein interacts with phosphotyrosine-binding domain proteins in the yeast two-hybrid system. FEBS Lett 397, 197-200. (Pubitemid 26414016)
9. Cao X, Sudhof TC (2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120. (Pubitemid 32625507)
10. Von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, Konietzko U (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117, 4435-4448. (Pubitemid 39360070)
11. Checler F, Sunyach C, Pardossi-Piquard R, Sévalle J, Vincent B, Kawarai T, Girardot N, St George-Hyslop P, da Costa CA (2007) The gamma/epsilon-secretase-derived APP intracel-lular domain fragments regulate p53. Curr Alzheimer Res 4, 423-426. (Pubitemid 47416636)
12. Ozaki T, Li Y, Kikuchi H, Tomita T, Iwatsubo T, Nakagawara A (2006) The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem Biophys Res Commun 351, 57-63. (Pubitemid 44635406)
13. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sévalle J, Vincent B, Boyer N, Kawarai T, Girardot N, StGeorge-Hyslop P, Checler F (2006) Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26, 6377-6385.
14. Maki CG, Huibregtse JM, Howley PM (1996) In vivoubiquiti-nation and proteasome-mediated degradation of p53. Cancer Res 56, 649-2654.
15. Almond JB, Cohen GM (2002) The proteasome: A novel target for cancer chemotherapy. Leukemia 16, 433-443. (Pubitemid 34449723)
16. Nair VD, McNaught KS, González-Maeso J, Sealfon SC, Olanow CW (2006) p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem 281, 39550-39560. (Pubitemid 46041915)
17. Müller T, Meyer HE, Egensperger R, Marcus K (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog Neurobiol 85, 393-406.
18. Cao X, Südhof TC (2004) Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem 279, 24601-24611. (Pubitemid 38725327)
19. Nakaya T, Suzuki T (2006) Role of APP phosphorylation in Fe65-dependent gene transactivation mediated by AICD. Genes Cells 11, 633-645. (Pubitemid 43744814)
20. Chang KA, Kim HS, Ha TY, Ha JW, Shin KY, Jeong YH, Lee JP, Park CH, Kim S, Baik TK, Suh YH (2006) Phosphoryla-tion of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol 26, 4327-4338. (Pubitemid 43788031)
21. Giliberto L, Zhou D, Weldon R, Tamagno E, De Luca P, Tabaton M, D'Adamio L (2008) Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role. Mol Neurodegener 2, 3-12.
22. Flood F, Murphy S, Cowburn RF, Lannfelt L, Walker B, Johnston JA (2005) Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site. Biochem J 385, 545-550. (Pubitemid 40165088)
23. Skovronsky DM, Pijak DS, Doms RW, Lee VM (2000) Adis-tinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP. Biochemistry 39, 810-817. (Pubitemid 30065051)
24. Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, Masters CL, Small DH (2001) The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur J Biochem 268, 5329-5336. (Pubitemid 32948359)
25. Nunan J, Williamson NA, Hill AF, Sernee MF, Masters CL, Small DH (2003) Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: Effect of C-terminal truncation on production of beta-amyloid protein. J Neurosci Res 74, 378-385. (Pubitemid 37362814)
26. Kerr ML, Small DH (2005) Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: Function, regulation of proteolysis, and implications for drug development. J Neurosci Res 80, 151-159. (Pubitemid 40676299)
27. Runyan K, Duckworth WC, Kitabchi AE, Huff G (1979) The effect of age on insulin-degrading activity in rat tissue. Diabetes 28, 324-325. (Pubitemid 9176781)
28. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ (1998) Insulin-degrading enzyme regulates extracellular levels of amyloidbeta-proteinbydegradation. J Biol Chem273, 32730-32738. (Pubitemid 28557658)
29. Kurochkin IV, Goto S (1994) Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin-degrading enzyme. FEBS Lett 345, 33-37.
30. Mukherjee A, Song E, Kihiko-Ehmann M, Goodman JP Jr, Pyrek JS, Estus S, Hersh LB (2000) Insulysinhydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci 20, 8745-8749.
31. Venugopal C, Pappolla MA, Sambamurti K (2007) Insulysin cleaves the APP Cytoplasmic Fragment atmultiple sites. Neurochem Res 32, 2225-2234. (Pubitemid 350059868)
32. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100, 4162-4167. (Pubitemid 36418174)
33. Authier F, Cameron PH, Taupin V (1996) Association of insulin-degrading enzyme with a 70kDa cytosolic protein in hepatoma cells. Biochem J 319, 149-158. (Pubitemid 26394752)
34. McDermott JR, Gibson AM (1997) Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: Involvement of insulin-degrading enzyme. Neurochem Res 22, 49-56.
35. Pérez A, Morelli L, Cresto JC, Castano EM (2000) Degrada-tionofsolubleamyloid beta-peptides 1-40, 1-42 andthe Dutch variant 1-40 Q by insulin degrading enzyme from Alzheimer disease and control brains. Neurochem Res 25, 247-255. (Pubitemid 30210091)
36. Buoso E, Lanni C, Schettini G, Govoni S, Racchi M (2010) beta-Amyloid precursor protein metabolism: Focus on the functions and degradation of its intracellular domain. Pharmacol Res 62, 308-317.
37. Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci USA 106, 18367-18372.
38. Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pim-plikar SW (2009) Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging 32, 1725-1729.
39. Nakayama K, Ohkawara T, Hiratochi M, Koh CS, Nagase H (2008) The intracellular domain of amyloid precursor protein induces neuron-specific apoptosis. Neurosci Lett 444, 127-131.
40. Ohkawara T, Nagase H, Koh CS, Nakayama K (2011) The amyloid precursor protein intracellular domain alters gene expression and induces neuron-specific apoptosis. Gene 475, 1-9.
41. Oddo S (2008) The ubiquitin-proteasome system in Alzheimer's disease. J Cell Mol Med 12, 363-373. (Pubitemid 351555121)
42. Klafki H, Abramowski D, Swoboda R, Paganetti PA, Staufen-biel M (1996) The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. J Biol Chem 271, 28655-28659. (Pubitemid 26374693)
43. Osera C, Fassina L, Amadio M, Venturini L, Buoso E, Magenes G, Govoni S, Ricevuti G, Pascale A (2011) Cyto-protective response induced by electromagnetic stimulation on SH-SY5Y human neuroblastoma cell line. Tissue Eng Part A 17, 2573-2582.
44. Pascale A, Amadio M, Scapagnini G, Lanni C, Racchi M, Provenzani A, Govoni S, Alkon DL, Quattrone A (2005) Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc Natl Acad Sci USA 102, 12065-12070. (Pubitemid 41291129)
45. Edbauer D, Willem M, Lammich S, Steiner H, Haass C (2002) Insulin-degrading enzyme rapidly removes the fj-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277, 13389-13393. (Pubitemid 34967931)
46. Ikura T, Ogryzko VV, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y (2000) Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell 102, 463-473.
47. Annaert W, De Strooper B (1999) Presenilins: Molecular switches between proteolysis and signal transduction. Trends Neurosci 22, 439-443. (Pubitemid 29447727)
48. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugar-man MC, Jannatipour M, Anliker B, Müller U, Saftig P, De Strooper B, Wolfe MS, Golde TE, LaFerla FM (2002) A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP Proc Natl Acad Sci USA 99, 4697-4702. (Pubitemid 34286047)
49. Hebert SS, Serneels L, Tolia A, Craessaerts K, Derks C, Filippov MA, Müller U, De Strooper B (2006) Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep 7, 739-745. (Pubitemid 43986273)
50. Waldron E, Isbert S, Kern A, Jaeger S, Martin AM, Hebert SS, Behl C, Weggen S, De Strooper B, Pietrzik CU (2008) Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Exp Cell Res 314, 2419-2433.
51. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, Hooper NM, Turner AJ (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. J Biol Chem 285, 41443-41454.
52. Keller JN, Hanni KB, Markesbery WR (2000) Impaired pro-teasome function in Alzheimer's disease. J Neurochem 75, 436-439. (Pubitemid 30418211)
53. Lam YA, Pickart CM, Alban A, Landon M, Jamieson C, Ramage R, Mayer RJ, Layfield R (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc Natl Acad Sci USA 97, 9902-9906.
54. Müller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, Kogel D, Prehn JH, Egensperger R (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18, 201-210. (Pubitemid 46066721)
55. Nakayama K, Nagase H, Koh CS, Ohkawara T (2011)-y-secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease. Cell Mol Neurobiol 31, 887-900.